Cipla Limited CC-Sep23.pdf · 2023-10-27
First one is on the gross margin improvement. So, we have cited that there was favorable product mix, etc., But would you say that improving US generics environment was one of the key drivers in this quarter in our sequential gross margin improvement?
We have mentioned that we are getting good traction with respect to several contracts in US and business development and everything . So, is that on account of lot of shortages that you are seeing or there is kind of pre -buying that is more driving that, what would be your assessment, so would it continue, let's say beyond Q3 in your sense or the activity is going to probably be muted little bit in Q4?